Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Arrivent Biopharma Inc (AVBP)

Arrivent Biopharma Inc (AVBP)
20.29 +0.75 (+3.84%) 13:41 ET [NASDAQ]
20.23 x 34 20.35 x 100
Realtime by (Cboe BZX)
20.23 x 34 20.35 x 100
Realtime - - (-) -
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
19.65
Day High
20.54
Open 19.81
Previous Close 19.54 19.54
Volume 51,390 51,390
Avg Vol 258,176 258,176
Stochastic %K 90.47% 90.47%
Weighted Alpha +9.75 +9.75
5-Day Change +2.06 (+11.18%) +2.06 (+11.18%)
52-Week Range 14.35 - 36.37 14.35 - 36.37
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 664,673
  • Shares Outstanding, K 34,016
  • Annual Sales, $ 0 K
  • Annual Income, $ -80,490 K
  • EBIT $ -94 M
  • EBITDA $ -94 M
  • 60-Month Beta 1.66
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.66
  • Number of Estimates 4
  • High Estimate -0.56
  • Low Estimate -0.70
  • Prior Year -0.70
  • Growth Rate Est. (year over year) +5.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.47 +32.13%
on 04/07/25
Period Open: 19.52
20.54 -0.49%
on 04/22/25
+0.92 (+4.71%)
since 03/21/25
3-Month
15.47 +32.13%
on 04/07/25
Period Open: 26.63
29.71 -31.20%
on 01/31/25
-6.19 (-23.24%)
since 01/22/25
52-Week
14.35 +42.44%
on 04/25/24
Period Open: 15.90
36.37 -43.80%
on 11/08/24
+4.54 (+28.55%)
since 04/22/24

Most Recent Stories

More News
ArriVent BioPharma Reports Full Year 2024 Financial Results

AVBP : 20.29 (+3.84%)
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers

AVBP : 20.29 (+3.84%)
ArriVent BioPharma Reports Third Quarter 2024 Financial Results

AVBP : 20.29 (+3.84%)
Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.

UPB : 9.88 (+1.75%)
JNJ : 156.36 (-0.36%)
CGON : 20.18 (-1.13%)
AVBP : 20.29 (+3.84%)

Business Summary

ArriVent BioPharma Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. ArriVent BioPharma Inc. is based in NEWTOWN SQUARE, Pa.

See More

Key Turning Points

3rd Resistance Point 22.60
2nd Resistance Point 21.15
1st Resistance Point 20.34
Last Price 20.29
1st Support Level 18.08
2nd Support Level 16.63
3rd Support Level 15.82

See More

52-Week High 36.37
Fibonacci 61.8% 27.96
Fibonacci 50% 25.36
Fibonacci 38.2% 22.76
Last Price 20.29
52-Week Low 14.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro